Evidence map›Paper›PMID 38319574›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

A Review of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography.

Kenji Hirata, Shiro Watanabe, Yoshimasa Kitagawa, Kohsuke Kudo

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. JACS Au · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kenji HirataDepartment of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. khirata@med.hokudai.ac.jp.
Shiro WatanabeDepartment of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Yoshimasa KitagawaOral Diagnosis and Medicine, Department of Oral Pathobiological Science, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Kohsuke KudoDepartment of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor hypoxia is an essential factor related to malignancy, prognosis, and resistance to treatment. Positron emission tomography (PET) is a modality that visualizes the distribution of radiopharmaceuticals administered into the body. PET imaging with [

Indexed as

MisonidazolePositron-Emission TomographyFastingFluorodeoxyglucose F18HumansHypoxiaFluorodeoxyglucose F18fluoromisonidazoleMisonidazole[14C]misonidazole[18F]fluorodeoxyglucose[18F]fluoromisonidazole[18F]FMISO[18F]FMISO-PETHypoxia radiotracerPETPositron emission tomography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.